All Stories

  1. Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies
  2. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
  3. Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis
  4. The safety and tolerability of the second-line injectable antituberculosis drugs in children
  5. Adverse effects of oral second-line antituberculosis drugs in children
  6. Multidrug-Resistant Tuberculosis in Children: Recent Developments in Diagnosis, Treatment and Prevention
  7. Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
  8. Probable Levofloxacin-associated Secondary Intracranial Hypertension in a Child With Multidrug-resistant Tuberculosis
  9. A review of the use of ethionamide and prothionamide in childhood tuberculosis
  10. Diagnosis of the Most Common Forms of Extrathoracic Tuberculosis in Children
  11. Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children
  12. Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis
  13. Antituberculosis drugs in children
  14. Fluoroquinolones for the treatment of tuberculosis in children
  15. Successful Treatment of a Child With Extensively Drug-Resistant Tuberculous Meningitis: Figure 1.
  16. In Reply
  17. Toxicity and Tolerability of Fluoroquinolone-based Preventive Therapy for Childhood Contacts of Multidrug-resistant Tuberculosis
  18. Acquired Drug Resistance During Inadequate Therapy in A Young Child with Tuberculosis
  19. Managing multidrug-resistant tuberculosis in children
  20. Linezolid for the treatment of drug-resistant tuberculosis in children: A review and recommendations
  21. False-negative post-18-month confirmatory HIV tests in HIV DNA PCR-positive children
  22. Oxidation of Cysteine residues in proteins by Myeloperoxidase (MPO) or HOCl in vitro produces Sulfenyl and Sulfonyl chloride intermediates † 1140